K. Oki - Jan 17, 2022 Form 3 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role: Chief Financial Officer
Signature: /s/ Josh Disbrow as attorney-in-facty for Mark K. Oki
Stock symbol: AYTU
Transactions as of: Jan 17, 2022
Transactions value $: $0
Form type: 3
Date filed: 1/19/2022, 10:40 AM
Next filing: Nov 28, 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 Power of Attorney